Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 2.4.1.144 extracted from

  • Wang, Y; Chen, S; Xu, Z; Chen, S; Yao, W; Gao, X
    GLP-1 receptor agonists downregulate aberrant GnT-III expression in Alzheimer's disease models through the Akt/GSK-3?/?-catenin signaling. (2018), Neuropharmacology, 131, 190-199.
    View publication on PubMed
Search for more literature for 2.4.1.144

Organism

Organism UniProt Comment Textmining